Phase I study of paclitaxel (Taxol®) plus vinorelbine (Navelbine®) in patients with untreated stage IIIb and IV non-small cell lung cancer

Lung Cancer

Volumn 31, Issue 2-3, 2001, Pages 295-301

  Breton, J L ^a   Westeel, V ^b   Jacoulet, P ^b   Mercier, M ^c   Chazard, M ^d   Depierre, A ^b  

^a General Hospital   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Dose finding; Febrile neutropenia; Non small cell lung cancer; Paclitaxel (Taxol); Vinorelbine

Indexed keywords

CIMETIDINE; DEXCHLORPHENIRAMINE; NAVELBINE; PACLITAXEL; PREDNISOLONE;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INFUSION; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MULTICENTER STUDY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FEVER; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0035142153     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00193-8     Document Type: Article

References (14)

1. Non-small cell lung cancer
2. Phase II study of Taxol in patients with untreated non-small-cell lung cancer
3. Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: the Eastern Cooperative Oncology Group results
4. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial
5. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer
6. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer
7. Modified weekly regimen with vinorelbine as a single agent in unresectable non-small cell lung cancer
8. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients
9. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial
10. Mechanism of action of Taxol
11. Interaction of vinblastine analogues with tubulin
12. Pilot study of vinorelbine (Navelbine) and paclitaxel in patients with refractory non-small cell lung cancer
13. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with G-CSF support in advanced non-small cell lung cancer
14. Vinorelbine, paclitaxel and carboplatin (VPC) for adenocarcinoma of the lung